Skip to content

Palaistra Systems, Inc.

Country not established

Devices
1

What Palaistra Systems, Inc. makes

Palaistra Systems, Inc. manufactures The Hermes System, a medical device designed for targeted tissue ablation, primarily used in interventional radiology procedures to treat vascular malformations and tumors.

The company’s portfolio is regulated under FDA Class II devices and includes products authorised via 510(k) clearance. The Hermes System is listed in the FDA’s 510(k) database, and the manufacturer operates from the United States.

AI-generated from registry data, 20 Sep 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • The Hermes System Ref K050929

    Active Regimes: 510(k) Registry: 510(k) Class:II

Frequently asked questions

How many devices does Palaistra Systems, Inc. have in the registry?

The registry currently lists 1 device for Palaistra Systems, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Palaistra Systems, Inc.'s devices?

Among its 1 most recently registered device, Palaistra Systems, Inc. has devices listed in FDA 510(k) (1 device).

What risk classes do Palaistra Systems, Inc.'s devices fall under?

Among its 1 most recently registered device, the classes recorded for Palaistra Systems, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

What are the newest devices from Palaistra Systems, Inc. in the registry?

The most recently registered devices listed for Palaistra Systems, Inc. include THE HERMES SYSTEM.

Generated automatically from registry data and not verified by a human reviewer.